...
首页> 外文期刊>The journal of immunology >CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
【24h】

CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients

机译:CD8 + CD103 +肿瘤浸润淋巴细胞是肿瘤特异的组织驻留性记忆T细胞,是肺癌患者生存的预后因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We had previously demonstrated the role of CD103 integrin on lung tumor-infiltrating lymphocyte (TIL) clones in promoting specific TCR-mediated epithelial tumor cell cytotoxicity. However, the contribution of CD103 on intratumoral T cell distribution and functions and the prognosis significance of TIL subpopulations in non–small cell lung carcinoma (NSCLC) have thus far not been systematically addressed. In this study, we show that an enhanced CD103+ TIL subset correlates with improved early stage NSCLC patient survival and increased intraepithelial lymphocyte infiltration. Moreover, our results indicate that CD8+CD103+ TIL, freshly isolated from NSCLC specimens, display transcriptomic and phenotypic signatures characteristic of tissue-resident memory T cells and frequently express PD-1 and Tim-3 checkpoint receptors. This TIL subset also displays increased activation-induced cell death and mediates specific cytolytic activity toward autologous tumor cells upon blockade of the PD-1–PD-L1 interaction. These findings emphasize the role of CD8+CD103+ tissue-resident memory T cells in promoting intratumoral CTL responses and support the rationale for using anti–PD-1 blocking Ab to reverse tumor-induced T cell exhaustion in NSCLC patients.
机译:我们以前已经证明CD103整联蛋白在肺肿瘤浸润淋巴细胞(TIL)克隆中在促进特异性TCR介导的上皮肿瘤细胞的细胞毒性中的作用。但是,到目前为止,CD103对非小细胞肺癌(NSCLC)中肿瘤内T细胞分布和功能的贡献以及TIL亚群的预后意义尚未得到系统的探讨。在这项研究中,我们表明,增强的CD103 + TIL亚群与早期NSCLC患者生存期的改善和上皮内淋巴细胞浸润的增加有关。此外,我们的结果表明,从NSCLC标本中新鲜分离的CD8 + CD103 + TIL显示出组织驻留记忆T细胞的转录组和表型特征,并经常表达PD-1和Tim-3检查点受体。这种TIL子集还表现出增加的激活诱导的细胞死亡,并在PD-1–PD-L1相互作用受阻后介导对自体肿瘤细胞的特异性溶细胞活性。这些发现强调了CD8 + CD103 +组织驻留性T细胞在促进肿瘤内CTL反应中的作用,并支持使用抗PD-1阻断Ab逆转NSCLC患者肿瘤诱导的T细胞衰竭的原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号